Structural basis for the inhibition of Aurora A kinase by a novel class of high affinity disubstituted pyrimidine inhibitors
Leslie W. Tari(Arcturus Therapeutics (United States)), Ronald V. Swanson(Diversitech (United States)), Duncan E. McRee, Jay C. Nix(Lawrence Berkeley National Laboratory), Daniel C. Bensen(State Street (United States)), Isaac Hoffman(Electronic BioSciences (United States)), Michael J. Hunter, Kirk Nelson(Arcturus Therapeutics (United States))
Cited by 37
Related Papers
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
|Cell|2021|656
Comparative Genomic Analysis of Archaeal Genotypic Variants in a Single Population and in Two Different Oceanic Provinces
|Applied and Environmental Microbiology|2002|171